Haleos Labs has informed that the Company has entered into strategic Development collaboration with HRV Global Life Sciences Private limited (HRV Global) to accelerate development and GMP manufacturing of orphan drug and niche therapeutic Active Pharmaceutical Ingredients (APls) for regulated and semi regulated markets.
The above information is a part of company’s filings submitted to BSE.